MKMagd Ahmed Kotb

Magd Ahmed Kotb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Magd Ahmed Kotb has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Corrigendum: Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial

    by Magd A. Kotb, Enas Abd El Satar, Ahmed M. Badr, Nazira A. Abdalla, Iman A. Abdelaziz

  • Open Access

    Corrigendum: Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial

    by Magd A. Kotb, Enas Abd El Satar, Ahmed M. Badr, Nazira A. Abdalla, Iman A. Abdelaziz

  • Open Access

    Timing of gene expression alters susceptibility to aflatoxicosis: a heterogeneous spectrum of disease in response to a single universal agent

    by Magd Ahmed Kotb, Nabil Mohamed Amr Lotfi, Ahmed Khaled Elhatw

    Aflatoxins (AFs) and their metabolites are a group of universally abundant organic compounds produced by fungus species of Aspergillus, that are seriously genotoxic and carcinogenic. They were ranked to be the most carcinogenic substances on Earth. AFs-induced disease is not limited to carcinogenicity and genotoxicity, they cause a spectrum of different morbidities to humans and other species, and the clinical spectrum changes with age at exposure. Aspergillus form AFs on grains, cereals, and other crops. They poison through ingestion, inhalation, mucous, or cutaneous routes. In healthy individuals, AFs are detoxified into non-toxic excretable compounds via hepatic phase 1 (CYP1A2, CYP34A, CYP3A5, and CYP3A7) and phase 2 (glutathione S transferase) enzymes and glutathione S-transferase M1 (GSTM1). Normally, gene expression of some family members of CYP family is beyond the first month of life, hence individuals younger than 1 month rely mainly on GSTM1 for detoxification of AFs. Despite contaminating up to 60–80% of crops, not all 60–80% of the population fall sick. The extent of AF-inflicted disease is not only related to the amount of AF and the timing of exposure. The genomics of bioactivation and detoxification capacity of the individual is a major decisive factor for susceptibility to AF-induced disease. At exposure to a sublethal dose of AFs, only those with defective detoxification capacity – The Kotb detoxification defect disease (KDDD)- will fall sick. The collective genomics of detoxification enzymes dictates the clinical phenotype in response to AFs exposure. In the susceptible subject with KDDD, AFs cause direct DNA and tissue injury and initiate a cascade of massive inflammatory response. Aflatoxin (AF)-induced disease ranges from the perinatally acquired aflatoxicosis biliary atresia: the Kotb disease, to massive hepatic necrosis and hepatocellular carcinoma (HCC). They are responsible for 4.6–28.2% of HCC globally. In this short review, we aim to highlight the disease burden inflicted by aflatoxicosis. The review also discusses the factors that affect and modulate the disease intensity and its clinical spectrum.


  • Open Access

    Extra-testicular Intra-scrotal Median Raphe Epidermoid Cyst Mimicking Polyorchidism in a Child

    by Alaa Obeida, Heba M. Taher, Basma Magdy, Moustafa Gad, Amjad Nayef, Sherifa Tawfik, Mohannad Ahmed, Abdullah Amr, Mohamed Elbarbary, Magd Ahmed Kotb, et al.

    Epidermoid cysts are encapsulated sebaceous cysts that contain keratin. They present at any age, yet they are commoner in adults. They mainly affect face, neck, trunk and to a lesser extent groin, but can potentially arise as a subepidermal nodule anywhere on the body. They develop from the follicular infundibulum, and are different from dermoid cysts as epidermoid cysts do not contain other adnexal structures of embryonic origin. Epidermoid cysts are mostly silent but can rupture, get inflamed, become infected or develop daughter cysts. Very rarely epidermoid cysts develop in proximity to testicles. They can be mistaken for a testicular tumor. The pre- operative diagnosis is essential to avoid unindicated testicular surgery. Magnetic resonance imaging (MRI) is vital for diagnosis. We report a 6-year-old child with a long standing painless scrotal swelling thought by the parents to be polyorchidism. They were alarmed by its recent rapid growth. By examination it was a median raphe cyst. Pre-operative imaging and operative surgical removal proved it to be an inflamed epidermoid cyst. The surgery was uncomplicated and the child had an uneventful recovery. Testicular epidermoid cysts in children are exceptionally rare, yet they can present as median raphe cysts. Inflammation within the epidermoid cyst presents clinically as rapid painless growth. Clinical examination, high index of suspicion and pre-operative MRI avoid unnecessary testicular surgery.


  • Open Access

    Perforated Appendix in Amyand Inguinal Hernia in a Neonate Presenting as Obstructed Oblique Inguinal Hernia: A Case Report and Review of Literature

    by Khaled S. Abdullateef, Youssef Eid, Maryam Aldaqaq, Hassan Marhoon, Sherifa Tawfik, Mohamed Fargaly, Rawan Abdelmaqsoud, Magd Ahmed Kotb, Sherif Kaddah, Heba Taher

    An Amyand hernia is defined as when the appendix is trapped within the sac of an inguinal hernia through a patent vaginal process. It was first described by Claudius Amyand, in 1735 during an appendectomy of a perforated appendix inside a hernial sac of an 11-year old child. Amyand hernia rare, constituting less than 1% of inguinal hernias. Amyand hernia is 3 times more likely to be diagnosed in children compared to adults due to the patency of vaginal process. Appendicitis or its perforation in Amyand hernia, complicate 0.1% of cases. Other variants include the presence of ileum, caecum or both in addition to the appendix. Isolated acute appendicitis in neonates is extremely rare, with a high mortality rate, and higher among those within Amyand hernia up to 30%. Perforated appendix in Amyand hernia is difficult to diagnose, as its clinical picture is not specific. We report a neonate 26 days old with perforated appendix in an Amyand inguinal hernia who presented by a picture of obstructed oblique inguinal hernia. He underwent emergency open inguinal exploration, herniotomy and appendicectomy. Despite the high mortality rate of Amyand hernia due to be peritoneal spread of sepsis, the boy survived complication free. Perforated appendix in Amyand hernia is exceptionally rare, and can present in the early neonatal period, its diagnosis and outcome rely on high index of suspicion and prompt surgical intervention.


  • Open Access

    Editorial: Elimination of biliary atresia

    by Magd Ahmed Kotb, Satoshi Ieiri, Sherif Mohamed Shehata

    Editorial: Elimination of biliary atresia


  • Open Access

    Medical-grade Spore-free Natural Honey is an Effective Choleretic in Neonatal Cholestasis: A Pilot Single-center Trial

    by Magd A. Kotb, Enas Abd El Satar, Ahmed M. Badr, Nazira A. Abdalla, Iman A. Abdelaziz

    Liver damage in cholestasis is multifactorial, yet bile acid-mediated hepatotoxicity is pivotal. Honey consumption has many physiological effects; it influences detoxification process (phase I, II and III), has antioxidant, anti-inflammatory, immune-stimulant, anti-ulcer, wound/burn healing effects and others. The bile acid ursodeoxycholic acid (UDCA) is currently used off-label to treat neonatal cholestasis. This study aimed to assess the effectiveness of spore-free natural honey to treat neonatal nonobstructive cholestasis.

  • Open Access

    Bone demineralization in a cohort of Egyptian pediatric liver transplant recipients: Single center pilot study

    by Magd A. Kotb, Lubna A. Fawaz, Rania A. Zeitoun, Yomna M. Shaalan, Nazira Aly, Hesham Abd El Kader, Gamal El Tagy, Haytham Esmat, Alaa F. Hamza, Hend Abd El Baky

    Liver transplantation (LT) is the definitive treatment of end-stage liver disease. The long-term survival following LT spurred more interest in improving the quality of life of patients. This was a cohort study that included 23 pediatric liver transplant recipients who underwent LT due to hereditary or metabolic liver diseases. Bone health assessment was performed at their last follow up clinically (anthropometric measures), biochemically and radiologically (Dual Energy X-ray Absorptiometry [DEXA] scans). Poor bone health was defined as z-score <−1. Mean age at LT was 5.77 years (standard deviation [SD] 3.64) and 43% were males. Biliary atresia was the most common cause of end stage liver disease (35%). Mean age at follow up was 14 years (SD 5.48) and mean follow up was 8 years (SD 4.12 years). Eleven patients (48%) had poor bone health (osteopenia 22% and osteoporosis 26%). On univariate analysis, being on steroids at last follow up (odds ratio [OR] 13.2, 95% confidence interval [CI] 1.23–140.67, P = .03), weight at last follow up (OR 0.45, 95% CI 0.20–0.99, P = .04), platelets at last follow up (OR 0.98, 95% CI 0.96–s0.99, P = .02), hemoglobin at last follow up (OR 0.33, 95% CI 0.12–0.89, P = .03) were significantly associated with poor bone health. None of the variables were significant on multivariate analysis. At most recent follow up, 48% of patients demonstrated poor bone health by DEXA scans. More studies are required to evaluate predictors of poor bone health after LT in children.


  • Open Access

    Congenital aflatoxicosis, mal-detoxification genomics & ontogeny trigger immune-mediated Kotb disease biliary atresia variant: SANRA compliant review

    by Magd A. Kotb, Ahmed Kotb, Sahar Talaat, Sherif M. Shehata, Nabil El Dessouki, Ahmed A. ElHaddad, Gamal El Tagy, Haytham Esmat, Sameh Shehata, Mohamed Hashim, et al.

    Biliary atresia (BA) is the most common indication for pediatric liver transplantation. We describe The BA variant: Kotb disease. Liver tissue in the Kotb disease BA is massively damaged by congenital aflatoxicosis resulting in inflammation, adhesions, fibrosis, bile duct proliferation, scarring, cholestasis, focal syncytial giant cell transformation, and typical immune response involving infiltration by CD4+, CD8+, CD68+, CD14+, neutrophil infiltration, neutrophil elastase spill, heavy loads of aflatoxin B1, accelerated cirrhosis, disruption of p53 and GSTPi, and have null glutathione S transferase M1 (GSTM1). All their mothers are heterozygous for GSTM1. This inability to detoxify aflatoxicosis results in progressive inflammatory adhesions and obliterative cholangiopathy early in life. The typical disruption of both p53 and GSTPi causes loss of fidelity of hepatic regeneration. Hence, regeneration in Kotb disease BA typically promotes accelerated cirrhosis. The immune response in Kotb disease BA is for damage control and initiation of regeneration, yet, this friendly fire incurs massive structural collateral damage. The Kotb disease BA is about actual ongoing hepatic entrapment of aflatoxins with lack of ability of safe disposal due to child detoxification-genomics disarray. The Kotb disease BA is a product of the interaction of persistent congenital aflatoxicosis, genetic lack of GSTM1 detoxification, ontogenically impaired activity of other hepatic detoxification, massive neutrophil-elastase, immune-induced damage, and disturbed regeneration. Ante-natal and neonatal screening for aflatoxicosis, avoiding cord milking, and stringent control of aflatoxicosis content of human, poultry and live-stock feeds might prove effective for prevention, prompt diagnosis and management based on our recent understanding of its patho-genomics.


  • Ataxia Telangiectasia: A Single Center Experience in a Decade

    by Lobna Mansour, Magd Ahmed Kotb, Ezzat El Sobkyb, Lamia Tarek, Walaa El Naggar, Mona Kamel

    Background: Ataxia Telangiectasia (A-T) is a rare neurodegenerative disorder that affects a number of different systems of the body.Aim of the work: To identify the spectrum of clinical presentations of children with A-T. Methods: Retrospective cohort study of data of 35 children with confirmed diagnosis of A-T. Results: A-T clinical spectrum was diverse with two distinct presentations according to age of onset of symptoms; classic early onset among 29 (82%) (mean age± SD= 2.9 ± 0.63 years) and variant late in 6 (17%) (mean age± SD=9.83 ± 1.34 years). In early onset A-T the leading presentations were classic; ataxia in 100%, telangiectasis (100%), dysarthria (62%), cerebellar atrophy (58%), repeated sinopulmonary infections (48%), autoimmune vitiligo in one child, but not peripheral neuropathy or postural scoliosis. While among those with late onset A-T, the leading presentations were extrapyramidal manifestations and dystonia in (66.6%), late development of ataxia (100%), telangiectasis (50%), dysarthria (66.6%), repeated sinopulmonary infections (16.6%), cerebellar atrophy (16.6%) and peripheral neuropathy (50%). All 35 (100%) had elevated alfa fetoprotein, 74% had reduced IgE levels and 68% had reduced IgA levels. Acute lymphoblastic leukemia (ALL) complicated the course of 17.2% and 16.6% of early and variant late onset A-T respectively, and preceded the onset of ataxia among 50% of affected cases. Conclusion: Ataxia telangiectasia is a rare neurologic disease with various clinical presentations. A-T clinical spectrum is diverse with two distinct presentations according to age of presentation: classic early onset and variant late onset. Immune dysregulation is more pronounced among the early onset group. ALL might be the initial presentation of A-T that precedes the onset of ataxia and of telangiectasis.